Negotiating and Structuring Strategic Alliances

June 15, 2002
Joe Zammit-Lucia

,
Chris Easley

,
Dechert London

,
David Schulman

BioPharm International, BioPharm International-06-01-2002, Volume 15, Issue 6

by David Schulman, Dechert London; and Joe Zammit-Lucia, Chris Easley, Cambridge Pharma Consultancy The job of many a biotech CEO is scrambling to find and secure funds to support the company's development projects. For many biopharmaceutical companies in early development stages, collaboration with "big pharma" is a compelling answer to the cashflow problem. But strategic alliances should benefit those on both sides of the negotiating table.